NM_006949.4:c.1034C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006949.4(STXBP2):​c.1034C>T​(p.Thr345Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 1,614,038 control chromosomes in the GnomAD database, including 209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T345A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 13 hom., cov: 32)
Exomes 𝑓: 0.014 ( 196 hom. )

Consequence

STXBP2
NM_006949.4 missense

Scores

2
11
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 7.80

Publications

20 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018442452).
BP6
Variant 19-7643172-C-T is Benign according to our data. Variant chr19-7643172-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 194241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0101 (1534/152280) while in subpopulation NFE AF = 0.0162 (1105/68020). AF 95% confidence interval is 0.0154. There are 13 homozygotes in GnomAd4. There are 676 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.1034C>T p.Thr345Met missense_variant Exon 13 of 19 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.1034C>T p.Thr345Met missense_variant Exon 13 of 19 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*1137C>T non_coding_transcript_exon_variant Exon 15 of 20 ENSP00000513686.1 A0A8V8TM65
ENSG00000268400ENST00000698368.1 linkn.*1137C>T 3_prime_UTR_variant Exon 15 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1538
AN:
152162
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00681
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00585
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0163
Gnomad OTH
AF:
0.0119
GnomAD2 exomes
AF:
0.0108
AC:
2708
AN:
251274
AF XY:
0.0108
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.00619
Gnomad ASJ exome
AF:
0.0243
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00588
Gnomad NFE exome
AF:
0.0163
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0143
AC:
20900
AN:
1461758
Hom.:
196
Cov.:
36
AF XY:
0.0144
AC XY:
10435
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.00260
AC:
87
AN:
33478
American (AMR)
AF:
0.00675
AC:
302
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
661
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00444
AC:
383
AN:
86252
European-Finnish (FIN)
AF:
0.00592
AC:
316
AN:
53362
Middle Eastern (MID)
AF:
0.0328
AC:
189
AN:
5768
European-Non Finnish (NFE)
AF:
0.0163
AC:
18108
AN:
1111954
Other (OTH)
AF:
0.0141
AC:
851
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1206
2412
3617
4823
6029
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1534
AN:
152280
Hom.:
13
Cov.:
32
AF XY:
0.00908
AC XY:
676
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00286
AC:
119
AN:
41560
American (AMR)
AF:
0.00673
AC:
103
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4826
European-Finnish (FIN)
AF:
0.00585
AC:
62
AN:
10596
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0162
AC:
1105
AN:
68020
Other (OTH)
AF:
0.0118
AC:
25
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0136
Hom.:
29
Bravo
AF:
0.0103
TwinsUK
AF:
0.0173
AC:
64
ALSPAC
AF:
0.0179
AC:
69
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0162
AC:
139
ExAC
AF:
0.0109
AC:
1318
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0160
EpiControl
AF:
0.0160

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 20, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Reported in 1 patient with -

not provided Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STXBP2: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Apr 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.12
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
.;T;.
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.99
D;D;D
MetaRNN
Benign
0.018
T;T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Pathogenic
3.1
.;M;.
PhyloP100
7.8
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-3.9
D;D;D
REVEL
Uncertain
0.54
Sift
Uncertain
0.028
D;D;D
Sift4G
Uncertain
0.024
D;D;D
Polyphen
1.0
.;D;D
Vest4
0.34
MPC
0.86
ClinPred
0.0072
T
GERP RS
4.3
PromoterAI
-0.027
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.55
gMVP
0.45
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117761837; hg19: chr19-7708058; COSMIC: COSV108782882; COSMIC: COSV108782882; API